lundi 11 juin 2018

Onco Actu du 11 juin 2018

3.1.1 Prévention - Tabac - e-cigs

Ex-smokers might be better off with high rather than low nicotine e-cigs [Cancer Research UK]

Vaping essays: E-cigarette sellers offering scholarships [AP]

4.5 Dép., diag. & prono. - Colorectal

How Early Is Too Early To Get A Colon Screening? [FiveThirtyEight]

5.1 Traitements - Pré-clinique

Scientists Pinpoint a New Cause of Resistance to EGFR-Targeting Drugs [Memorial Sloan Kettering Cancer Center]

5.10 Traitements - Essais

Selumetinib Continues to Show Promise in Children with NF1 [NCI]

Protecting the accuracy of clinical trial data in China [BMJ Blogs]

Going further to make all clinical trials public [MRC]

5.12.5 Immunothérapies - Pharma

Sound familiar? China/US biotech hybrid lands rights to cancer drugs, cash and a team of development vets to launch Oncologie [EndPoints]

5.12.7 Immunothérapies - vaccins

Advaxis cuts staff as it seeks partner for troubled cancer vaccine [FierceBiotech]

5.2 Pharma

Ipsen moves U.S. headquarters to Kendall Square [FierceBiotech]

After snatching up Shire’s cancer unit, French pharma giant Servier to expand US presence with Kendall Square innovation office [EndPoints]

5.3.4 Traitements - AMM (FDA, EMA,...)

The EU approves Tagrisso for 1st-line treatment of EGFR-mutated non-small cell lung cancer [AstraZeneca]

AbbVie Announces U.S. FDA Approval of VENCLEXTA® (venetoclax tablets) in Combination with Rituximab as a Fixed Duration Treatment for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients Who Have Received One Prior Therapy [AbbVie]

5.4 Traitements - Economie

Merck impresses NICE with Keytruda data—and discounts—cueing up a CDF switch [FiercePharma]

To all involved — we have a problem [Nature Reviews Clincal Oncology] ASCO (général) - Industriels

Visualize: ASCO 2018’s winners and losers [EndPoints]

6.1 Observation

Low-fat diet tied to improved breast cancer survival odds [Reuters]

6.10 Politiques

The fight has begun over Europe’s big budget increase for science [Science]

EU to world: join our €100-billion research programme [Nature]

6.10.1 Politiques (USA)

STAR Act Aims to Boost Pediatric Research [Cancer Research Catalyst]

6.11 Patients

You, Me and the Big C: 'When you talk about cancer, you normalise it' [The Guardian]

6.7.1 IA/bioinformatique

AI cancer detectors [The Guardian]